147 related articles for article (PubMed ID: 11168337)
21. GAD antibodies in T1D and LADA--relations to age, BMI, c-peptide, IA-2 and HLA-DRB1*03 and DRB1*04 alleles.
Weber P; Ambrosova P; Canov P; Weberova D; Kuklinek P; Meluzinova H; Matejovska-Kubesova H; Cejkova P; Bielakova K; Cerna M
Adv Gerontol; 2011; 24(2):312-8. PubMed ID: 21957594
[TBL] [Abstract][Full Text] [Related]
22. Insulin-dependent diabetes mellitus associated with autoimmune thyroiditis and rheumatoid arthritis.
Yamato E; Ikegami H; Kawaguchi Y; Fujisawa T; Hamada Y; Ueda H; Shintani M; Ogihara T
Am J Med Sci; 1997 Jan; 313(1):64-6. PubMed ID: 9001168
[TBL] [Abstract][Full Text] [Related]
23. HLA-typing, clinical, and immunological characterization of youth with type 2 diabetes mellitus phenotype from the German/Austrian DPV database.
Awa WL; Boehm BO; Rosinger S; Achenbach P; Ziegler AG; Krause S; Meissner T; Wiegand S; Reinehr T; Kapellen T; Karges B; Eiermann T; Schober E; Holl RW;
Pediatr Diabetes; 2013 Dec; 14(8):562-74. PubMed ID: 23627341
[TBL] [Abstract][Full Text] [Related]
24. GAD antibody negative NIDDM in adult black subjects with diabetic ketoacidosis and increased frequency of human leukocyte antigen DR3 and DR4. Flatbush diabetes.
Banerji MA; Chaiken RL; Huey H; Tuomi T; Norin AJ; Mackay IR; Rowley MJ; Zimmet PZ; Lebovitz HE
Diabetes; 1994 Jun; 43(6):741-5. PubMed ID: 8194658
[TBL] [Abstract][Full Text] [Related]
25. Possible human leukocyte antigen-mediated genetic interaction between type 1 and type 2 Diabetes.
Li H; Lindholm E; Almgren P; Gustafsson A; Forsblom C; Groop L; Tuomi T
J Clin Endocrinol Metab; 2001 Feb; 86(2):574-82. PubMed ID: 11158011
[TBL] [Abstract][Full Text] [Related]
26. Progression to insulin-requiring diabetes in seronegative prediabetic subjects: the role of two HLA-DQ high-risk haplotypes.
Pietropaolo M; Becker DJ; LaPorte RE; Dorman JS; Riboni S; Rudert WA; Mazumdar S; Trucco M
Diabetologia; 2002 Jan; 45(1):66-76. PubMed ID: 11845225
[TBL] [Abstract][Full Text] [Related]
27. Genetic and diabetic auto-antibody markers in Saudi children with type 1 diabetes.
Manan H; Angham AM; Sitelbanat A
Hum Immunol; 2010 Dec; 71(12):1238-42. PubMed ID: 20858521
[TBL] [Abstract][Full Text] [Related]
28. Autoantibodies and high-risk HLA susceptibility markers in first-degree relatives of Brazilian patients with type 1 diabetes mellitus: a progression to disease based study.
Alves LI; Davini E; Correia MR; Fukui RT; Santos RF; Cunha MR; Rocha DM; Volpini WM; Silva ME
J Clin Immunol; 2012 Aug; 32(4):778-85. PubMed ID: 22402866
[TBL] [Abstract][Full Text] [Related]
29. The low prevalence of immunogenetic markers in Korean adult-onset IDDM patients.
Park Y; Lee H; Koh CS; Min H; Rowley M; Mackay IR; Zimmet P; McCarthy B; McCanlies E; Dorman J; Trucco M
Diabetes Care; 1996 Mar; 19(3):241-5. PubMed ID: 8742569
[TBL] [Abstract][Full Text] [Related]
30. Frequency, immunogenetics, and clinical characteristics of latent autoimmune diabetes in China (LADA China study): a nationwide, multicenter, clinic-based cross-sectional study.
Zhou Z; Xiang Y; Ji L; Jia W; Ning G; Huang G; Yang L; Lin J; Liu Z; Hagopian WA; Leslie RD;
Diabetes; 2013 Feb; 62(2):543-50. PubMed ID: 23086039
[TBL] [Abstract][Full Text] [Related]
31. HLA-encoded susceptibility to insulin-dependent diabetes mellitus is determined by DR and DQ genes as well as their linkage disequilibria in a Chinese population.
Huang HS; Peng JT; She JY; Zhang LP; Chao CC; Liu KH; She JX
Hum Immunol; 1995 Dec; 44(4):210-9. PubMed ID: 8770634
[TBL] [Abstract][Full Text] [Related]
32. IA-2 antibody prevalence and risk assessment of early insulin requirement in subjects presenting with type 2 diabetes (UKPDS 71).
Bottazzo GF; Bosi E; Cull CA; Bonifacio E; Locatelli M; Zimmet P; Mackay IR; Holman RR
Diabetologia; 2005 Apr; 48(4):703-8. PubMed ID: 15765222
[TBL] [Abstract][Full Text] [Related]
33. Anti-thyroid peroxidase antibody, IA-2 antibody, and fasting C-peptide levels predict beta cell failure in patients with latent autoimmune diabetes in adults (LADA)--a 5-year follow-up of the Ehime study.
Murao S; Kondo S; Ohashi J; Fujii Y; Shimizu I; Fujiyama M; Ohno K; Takada Y; Nakai K; Yamane Y; Osawa H; Makino H
Diabetes Res Clin Pract; 2008 Apr; 80(1):114-21. PubMed ID: 18342387
[TBL] [Abstract][Full Text] [Related]
34. Cytotoxic T lymphocyte antigen 4 gene polymorphism confers susceptibility to type 1 diabetes in Japanese children: analysis of association with HLA genotypes and autoantibodies.
Kikuoka N; Sugihara S; Yanagawa T; Ikezaki A; Kim HS; Matsuoka H; Kobayashi Y; Wataki K; Konda S; Sato H; Miyamoto S; Sasaki N; Sakamaki T; Niimi H; Murata M
Clin Endocrinol (Oxf); 2001 Nov; 55(5):597-603. PubMed ID: 11894970
[TBL] [Abstract][Full Text] [Related]
35. Antibodies to glutamic acid decarboxylase in young Chinese diabetic patients.
Ko GT; Chan JC; Yeung VT; Chow CC; Li JK; Lau MS; Mackay IR; Rowley MJ; Zimmet P; Cockram CS
Ann Clin Biochem; 1998 Nov; 35 ( Pt 6)():761-7. PubMed ID: 9838990
[TBL] [Abstract][Full Text] [Related]
36. Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies.
Tuomi T; Carlsson A; Li H; Isomaa B; Miettinen A; Nilsson A; Nissén M; Ehrnström BO; Forsén B; Snickars B; Lahti K; Forsblom C; Saloranta C; Taskinen MR; Groop LC
Diabetes; 1999 Jan; 48(1):150-7. PubMed ID: 9892237
[TBL] [Abstract][Full Text] [Related]
37. Immunogenetic analysis suggests different pathogenesis for obese and lean African-Americans with diabetic ketoacidosis.
Umpierrez GE; Woo W; Hagopian WA; Isaacs SD; Palmer JP; Gaur LK; Nepom GT; Clark WS; Mixon PS; Kitabchi AE
Diabetes Care; 1999 Sep; 22(9):1517-23. PubMed ID: 10480519
[TBL] [Abstract][Full Text] [Related]
38. Metabolic and immunologic features of Chinese patients with atypical diabetes mellitus.
Tan KC; Mackay IR; Zimmet PZ; Hawkins BR; Lam KS
Diabetes Care; 2000 Mar; 23(3):335-8. PubMed ID: 10868861
[TBL] [Abstract][Full Text] [Related]
39. Relationship between HLA-DQ and -DR genotypes and clinical characteristics in a French population of Type 1 diabetic patients.
Zevaco-Mattei C; Reviron D; Atlan-Gepner C; Botti G; Simonin G; Lassmann-Vague V; Vague P; Mercier P; Vialettes B
Diabet Med; 1999 Mar; 16(3):201-6. PubMed ID: 10227564
[TBL] [Abstract][Full Text] [Related]
40. Increased risk for endocrine autoimmunity in Italian type 2 diabetic patients with GAD65 autoantibodies.
Gambelunghe G; Forini F; Laureti S; Murdolo G; Toraldo G; Santeusanio F; Brunetti P; Sanjeevi CB; Falorni A
Clin Endocrinol (Oxf); 2000 May; 52(5):565-73. PubMed ID: 10792335
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
